Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons
Mutations in SPG11 cause a complicated autosomal recessive form of hereditary spastic paraplegia (HSP). Mechanistically, there are indications for the dysregulation of the GSK3β/βCat signaling pathway in SPG11. In this study, we tested the therapeutic potential of the GSK3β inhibitor, tideglusib, to...
Main Authors: | Tatyana Pozner, Annika Schray, Martin Regensburger, Dieter Chichung Lie, Ursula Schlötzer-Schrehardt, Jürgen Winkler, Soeren Turan, Beate Winner |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2018.00914/full |
Similar Items
-
Neuropsychology and MRI correlates of neurodegeneration in SPG11 hereditary spastic paraplegia
by: Kathrin S. Utz, et al.
Published: (2022-07-01) -
Increased baroreceptor sensitivity in a patient with hereditary spastic paraplegia – type SPG11
by: Fischer Gerald, et al.
Published: (2018-09-01) -
A Rare Cause of Ataxia: SPG7 Mutation
by: Afra Çelik, et al.
Published: (2022-09-01) -
More autosomal dominant SPG18 cases than recessive? The first AD‐SPG18 pedigree in Chinese and literature review
by: Shuai Chen, et al.
Published: (2021-12-01) -
EFFECT OF TIDEGLUSIB WITH BONE GRAFTING ON NEW BONE FORMATION
by: Ufuk Taşdemir, et al.
Published: (2021-09-01)